Cargando…

GPCRs Revisited: New Insights Lead to Novel Drugs

GPCRs play a critical role in human physiology and are a prime target for drug discovery globally. Novel insights into the functions of GPCRs are providing unique approaches to modulate these proteins to generate unique drug candidates. Next generation ligands include those with novel pharmacologies...

Descripción completa

Detalles Bibliográficos
Autores principales: Eglen, Richard M., Reisine, Terry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053956/
http://dx.doi.org/10.3390/ph4020244
_version_ 1782320475952644096
author Eglen, Richard M.
Reisine, Terry
author_facet Eglen, Richard M.
Reisine, Terry
author_sort Eglen, Richard M.
collection PubMed
description GPCRs play a critical role in human physiology and are a prime target for drug discovery globally. Novel insights into the functions of GPCRs are providing unique approaches to modulate these proteins to generate unique drug candidates. Next generation ligands include those with novel pharmacologies such as allosteric regulators as well pepducins, that affect the interaction of GPCRs with G proteins, to either block selective receptor signaling pathways or mimic the actions of intracellular domains of receptors, thereby activating GPCRs to signal selectively to intracellular pathways. We will review these new concepts and then discuss how they may be exploited using modern discovery technologies to provide novel drug candidates for the future.
format Online
Article
Text
id pubmed-4053956
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-40539562014-06-12 GPCRs Revisited: New Insights Lead to Novel Drugs Eglen, Richard M. Reisine, Terry Pharmaceuticals (Basel) Review GPCRs play a critical role in human physiology and are a prime target for drug discovery globally. Novel insights into the functions of GPCRs are providing unique approaches to modulate these proteins to generate unique drug candidates. Next generation ligands include those with novel pharmacologies such as allosteric regulators as well pepducins, that affect the interaction of GPCRs with G proteins, to either block selective receptor signaling pathways or mimic the actions of intracellular domains of receptors, thereby activating GPCRs to signal selectively to intracellular pathways. We will review these new concepts and then discuss how they may be exploited using modern discovery technologies to provide novel drug candidates for the future. MDPI 2011-01-25 /pmc/articles/PMC4053956/ http://dx.doi.org/10.3390/ph4020244 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Eglen, Richard M.
Reisine, Terry
GPCRs Revisited: New Insights Lead to Novel Drugs
title GPCRs Revisited: New Insights Lead to Novel Drugs
title_full GPCRs Revisited: New Insights Lead to Novel Drugs
title_fullStr GPCRs Revisited: New Insights Lead to Novel Drugs
title_full_unstemmed GPCRs Revisited: New Insights Lead to Novel Drugs
title_short GPCRs Revisited: New Insights Lead to Novel Drugs
title_sort gpcrs revisited: new insights lead to novel drugs
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053956/
http://dx.doi.org/10.3390/ph4020244
work_keys_str_mv AT eglenrichardm gpcrsrevisitednewinsightsleadtonoveldrugs
AT reisineterry gpcrsrevisitednewinsightsleadtonoveldrugs